Daniel J Morgan1, Daniel J Diekema, Kent Sepkowitz, Eli N Perencevich. 1. Veterans Affairs Maryland Health Care System, and the Department of Epidemiology and Preventative Medicine, University of Maryland, School of Medicine, Baltimore, MD, USA. dmorgan@epi.umaryland.edu
Abstract
BACKGROUND: Contact Precautions (CP) are a standard method for preventing patient-to-patient transmission of multiple drug-resistant organisms (MDROs) in hospital settings. With the ongoing worldwide concern for MDROs including methicillin-resistant Staphylococcus aureus (MRSA) and broadened use of active surveillance programs, an increasing number of patients are being placed on CP. Whereas few would argue that CP are an important tool in infection control, many reports and small studies have observed worse noninfectious outcomes in patients on CP. However, no review of this literature exists. METHODS: We systematically reviewed the literature describing adverse outcomes associated with CP. We identified 15 studies published between 1989 and 2008 relating to adverse outcomes from CP. Nine were higher quality based on standardized collection of data and/or inclusion of control groups. RESULTS: Four main adverse outcomes related to CP were identified in this review. These included less patient-health care worker contact, changes in systems of care that produce delays and more noninfectious adverse events, increased symptoms of depression and anxiety, and decreased patient satisfaction with care. CONCLUSION: Although CP are recommended by the Centers for Disease Control and Prevention as an intervention to control spread of MDROs, our review of the literature demonstrates that this approach has unintended consequences that are potentially deleterious to the patient. Measures to ameliorate these deleterious consequences of CP are urgently needed.
BACKGROUND: Contact Precautions (CP) are a standard method for preventing patient-to-patient transmission of multiple drug-resistant organisms (MDROs) in hospital settings. With the ongoing worldwide concern for MDROs including methicillin-resistant Staphylococcus aureus (MRSA) and broadened use of active surveillance programs, an increasing number of patients are being placed on CP. Whereas few would argue that CP are an important tool in infection control, many reports and small studies have observed worse noninfectious outcomes in patients on CP. However, no review of this literature exists. METHODS: We systematically reviewed the literature describing adverse outcomes associated with CP. We identified 15 studies published between 1989 and 2008 relating to adverse outcomes from CP. Nine were higher quality based on standardized collection of data and/or inclusion of control groups. RESULTS: Four main adverse outcomes related to CP were identified in this review. These included less patient-health care worker contact, changes in systems of care that produce delays and more noninfectious adverse events, increased symptoms of depression and anxiety, and decreased patient satisfaction with care. CONCLUSION: Although CP are recommended by the Centers for Disease Control and Prevention as an intervention to control spread of MDROs, our review of the literature demonstrates that this approach has unintended consequences that are potentially deleterious to the patient. Measures to ameliorate these deleterious consequences of CP are urgently needed.
Authors: Sally W Aboelela; Lisa Saiman; Patricia Stone; Franklin D Lowy; Dave Quiros; Elaine Larson Journal: Am J Infect Control Date: 2006-10 Impact factor: 2.918
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Ann Intern Med Date: 2007-10-16 Impact factor: 25.391
Authors: Stephen G Weber; Susan S Huang; Shannon Oriola; W Charles Huskins; Gary A Noskin; Kathleen Harriman; Russell N Olmsted; Marc Bonten; Tammy Lundstrom; Michael W Climo; Mary-Claire Roghmann; Cathryn L Murphy; Tobi B Karchmer Journal: Infect Control Hosp Epidemiol Date: 2007-02-07 Impact factor: 3.254
Authors: Jean-Christophe Lucet; Karine Grenet; Laurence Armand-Lefevre; Marion Harnal; Elisabeth Bouvet; Bernard Regnier; Antoine Andremont Journal: Infect Control Hosp Epidemiol Date: 2005-02 Impact factor: 3.254
Authors: Leanne B Gasink; Karyn Singer; Neil O Fishman; William C Holmes; Mark G Weiner; Warren B Bilker; Ebbing Lautenbach Journal: Infect Control Hosp Epidemiol Date: 2008-03 Impact factor: 3.254
Authors: J R Zahar; M Garrouste-Orgeas; A Vesin; C Schwebel; A Bonadona; F Philippart; C Ara-Somohano; B Misset; J F Timsit Journal: Intensive Care Med Date: 2013-08-31 Impact factor: 17.440
Authors: Eric Yanke; Caroline Zellmer; Sarah Van Hoof; Helene Moriarty; Pascale Carayon; Nasia Safdar Journal: Am J Infect Control Date: 2015-03-01 Impact factor: 2.918
Authors: Lindsay D Croft; Michael Liquori; James Ladd; Hannah Day; Lisa Pineles; Elizabeth Lamos; Ryan Arnold; Preeti Mehrotra; Jeffrey C Fink; Patricia Langenberg; Linda Simoni-Wastila; Eli Perencevich; Anthony D Harris; Daniel J Morgan Journal: Infect Control Hosp Epidemiol Date: 2015-08-17 Impact factor: 3.254
Authors: Carol E Muenks; Whitney C Sewell; Patrick G Hogan; Ryley M Thompson; David G Ross; Jeffrey W Wang; John J Morelli; Sarah J Gehlert; Stephanie A Fritz Journal: J Pediatr Date: 2018-05-11 Impact factor: 4.406
Authors: Anthony D Harris; Lisa Pineles; Beverly Belton; J Kristie Johnson; Michelle Shardell; Mark Loeb; Robin Newhouse; Louise Dembry; Barbara Braun; Eli N Perencevich; Kendall K Hall; Daniel J Morgan; Syed K Shahryar; Connie S Price; Joseph J Gadbaw; Marci Drees; Daniel H Kett; L Silvia Muñoz-Price; Jesse T Jacob; Loreen A Herwaldt; Carol A Sulis; Deborah S Yokoe; Lisa Maragakis; Matthew E Lissauer; Marcus J Zervos; David K Warren; Robin L Carver; Deverick J Anderson; David P Calfee; Jason E Bowling; Nasia Safdar Journal: JAMA Date: 2013-10-16 Impact factor: 56.272
Authors: Charlesnika T Evans; Jennifer N Hill; Marylou Guihan; Amy Chin; Barry Goldstein; Michael S A Richardson; Vicki Anderson; Kathleen Risa; Susan Kellie; Kenzie A Cameron Journal: J Spinal Cord Med Date: 2013-10-24 Impact factor: 1.985